Year: 2018
Type: review
Abstract: The pathogenesis of hepatocellular carcinoma (HCC) is poorly understood, but recent advances in genomics have increased our understanding of the mechanisms by which hepatitis B virus, hepatitis C virus, alcohol, fatty liver disease, and other environmental factors, such as aflatoxin, cause liver cancer. Genetic analyses of liver tissues from patients have provided important information about tumor initiation and progression. Findings from these studies can potentially be used to individualize the management of HCC. In addition to sorafenib, other multi-kinase inhibitors have been approved recently for treatment of HCC, and the preliminary success of immunotherapy has raised hopes. Continued progress in genomic medicine could improve classification of HCCs based on their molecular features and lead to new treatments for patients with liver cancer.
Source: Gastroenterology
Institutions: Stanford University, Inserm, Université Sorbonne Paris Nord, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Institut de Biologie Paris-Seine, Génomique Fonctionnelle des Tumeurs Solides, Hôpital Jean-Verdier, Université Paris Diderot, Université Paris Descartes, Mayo Clinic, Hôpital Européen Georges-Pompidou
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,180
Funders: Mayo Clinic, Bayer, Gilead Sciences, Ariad Pharmaceuticals, Georgia Clinical and Translational Science Alliance, Institut National de la Santé et de la Recherche Médicale, Ligue Contre le Cancer, Institut National Du Cancer, Fondation Mérieux, National Institutes of Health, Center for Cell Signaling in Gastroenterology, Mayo Clinic, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC), G1828094709, G2581418637, Mayo Clinic Center for Clinical and Translational Science (CCaTS), G4676174703, G473885138, G703126342, Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma, G7840490616, Functional Proteomic Analysis and Biomarker Identification in a Novel Mouse Model of Metastatic Hepatocellular Carcinoma (HCC), G840437197, G9000319385, Mayo Clinic Comprehensive Cancer Center Support Grant, Mayo Clinic Hepatobiliary SPORE, Mayo Center for Cell Signaling in Gastroenterology, Mayo Clinic Center for Clinical and Translational Science (CCaTS)
OpenAlex ID: W2899265013
